FindTrial
Sign In

A study to find out consequences of various treatment of lupus nephritis, which is a disease involving the kidneys ;information regarding the drugs and the amount of money spent by the patient for treatment.

Evaluation of the clinical outcome, prescription patterns and cost of treatment in patients with lupus nephritis in a tertiary care hospital.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/02/023480
Enrollment
70
Registered
2020-02-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M321- Systemic lupus erythematosus withorgan or system involvement

Interventions

None listed

Sponsors

Seth GS Medical College and KEM Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male or female patients, whose age is 16 and above ,attending Rheumatology clinic (OPD and IPD). 2. All classes of lupus nephritis diagnosed by ACR criteria, with proven renal biopsy ISN/RPS lupus nephritis. 3. Assent from patient and written informed consent from parent or guardian whose age is 16- 4. Written informed consent for patients whose age is > 18 years.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women. 2. Patients with lupus nephritis presenting with overlap syndrome and mixed connective tissue disorders. ( interfere with interpretation related to outcome of LN). 3. Critically ill patients of SLE with lupus nephritis requiring emergency management / admitted in ICU. 4. Co morbidities: Hypertension, diabetes, not controlled with medications. (interfere with clinical outcome assessment). 5. Patients diagnosed as tuberculosis, or hepatitis B, or hepatitis C (break in Rx or any severe systemic illness which will interfere with interpretation related to outcome of LN in the opinion of investigators. 6. Drug-induced lupus (Confounding factor).

Design outcomes

Primary

MeasureTime frame
To find out the clinical outcome in terms of disease activity in patients with lupus nephritis in Rheumatology clinic in a tertiary medical care hospital.Timepoint: Multiple time points (longitudinal study) and single time point cross sectional study(cross sectional study,18 months duration).—

Secondary

MeasureTime frame
1. To study the prescription patterns in treatment of lupus nephritis 2. To evaluate the Cost of treatment of lupus nephritis from Patientsâ?? Perspective. 3. To assess the type, causality, severity and preventability of ADRs in lupus nephritis patients.Timepoint: Multiple time points—

Countries

India

Contacts

Public ContactMerin Eldhose K

Seth G.S. Medical College and KEM Hospital, Mumbai

merinsara11@gmail.com9500381947

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026